Aperture will advance APRTX-001 as a potential treatment for ALS and frontotemporal dementia, with possible expansion for use ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Three of the mammoth samples yielded ancient RNA fragments, particularly the sample from Yuka. Previously assumed to be a female mammoth, their analysis showed that Yuka had fragments of RNA from ...

Three research scientist entrepreneurs with roots in university labs and life sciences startup companies have announced formation of what they deem “the first AI-powered cell manufacturing platform,” ...

Scientists reveal how mapping cellular interactions in the heart could unlock better recovery after heart attacks.

Prime Medicine, Inc. ( PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease November 12, 2025 8:00 AM EST ...

Background Eosinophilic oesophagitis (EoE) is a chronic allergic disease characterised by oesophageal epithelial remodelling, barrier dysfunction and inflammation. The transcription factor forkhead ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

Study shows aging tissues resist tumors even as mutations accumulate. Reveals why cancer rates decline after 85 and opens treatment paths.

A Penn-led research team has uncovered how hydralazine, one of the oldest blood pressure medications and a standard treatment for preeclampsia, functions at the molecular level.

Union Minister of State for Health and Family Welfare, Smt Anupriya Singh Patel recently delivered the keynote address at the ...